Search - tctmd.com

Displaying 81 - 100 of 554

Sort: Relevancy | Date

News Daily News

STS Releases New Risk-Prediction Tools for Emerging Surgical Scenarios

Yael L. Maxwell

May 01, 2024

Another Win for TAVI in Low-to-Intermediate Risk Patients

News Conference News ACC 2024

Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6

Yael L. Maxwell

April 08, 2024

News Conference News ACC 2024

TAVI, SAVR Rates Roughly Equal for Patients Younger Than 65 in New England

Yael L. Maxwell

April 05, 2024

News Conference News CRT 2024

Open SESAME? Transcatheter Myotomy Shows Promise for LVOT Obstruction

L.A. McKeown

March 12, 2024

Presentation

A Critical Assessment of Valve Performance and Outcomes in Patients at Low Risk for Surgery

February 28, 2024

News Daily News

FDA Panel Takes a Positive View of TriClip in Tricuspid Regurgitation

Michael O'Riordan

February 13, 2024

News Conference News STS 2024

Isolated vs Concomitant SAVR Offer Similar 5-Year Outcomes: PARTNER 3

Yael L. Maxwell

February 09, 2024

News Conference News STS 2024

SAVR After Failed TAVI on the Rise, With High Mortality

Yael L. Maxwell

February 05, 2024

News Conference News STS 2024

TAVI, SAVR Almost Equally Performed in California Patients Under 60

Yael L. Maxwell

February 01, 2024

News Daily News

Lower Mortality With M-TEER vs Surgery, but Devil Is in the Details

Michael O'Riordan

January 25, 2024

News Daily News

Top Structural Heart News of 2023

Todd Neale

January 02, 2024

News Opinion Editor's Corner

The Biggest News of 2023: TCTMD’s Top 10

Shelley Wood

January 01, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2023

Shelley Wood

November 30, 2023

News Conference News PCR London Valves 2023

Looking for a Winner Between Long-term TAVI Trials? Don’t, Experts Urge

Shelley Wood

November 27, 2023

News Conference News TCT 2023

Post-TAVI Conduction Abnormalities: EP Study, Registry Data Provide Snapshots

Caitlin E. Cox

November 03, 2023

News Conference News TCT 2023

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

Michael O'Riordan

November 01, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2023

Shelley Wood

November 01, 2023

News Conference News TCT 2023

VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli

L.A. McKeown

October 27, 2023

Presentation TCT 2023

TCT 444: Mid to Long-Term Outcomes of Transcatheter vs. Surgical Aortic Valve Replacement in Low-Risk Patients with Severe Aortic Stenosis: A Systematic Review and Meta-Analysis

Presenter: Muhammad Adil Afzal

October 26, 2023

News Conference News TCT 2023

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Michael O'Riordan

October 24, 2023

Advertisement

STS Releases New Risk-Prediction Tools for Emerging Surgical Scenarios

Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6

TAVI, SAVR Rates Roughly Equal for Patients Younger Than 65 in New England

Open SESAME? Transcatheter Myotomy Shows Promise for LVOT Obstruction

A Critical Assessment of Valve Performance and Outcomes in Patients at Low Risk for Surgery

FDA Panel Takes a Positive View of TriClip in Tricuspid Regurgitation

Isolated vs Concomitant SAVR Offer Similar 5-Year Outcomes: PARTNER 3

SAVR After Failed TAVI on the Rise, With High Mortality

TAVI, SAVR Almost Equally Performed in California Patients Under 60

Lower Mortality With M-TEER vs Surgery, but Devil Is in the Details

Top Structural Heart News of 2023

The Biggest News of 2023: TCTMD’s Top 10

TCTMD’s Top 10 Most Popular Stories for November 2023

Looking for a Winner Between Long-term TAVI Trials? Don’t, Experts Urge

Post-TAVI Conduction Abnormalities: EP Study, Registry Data Provide Snapshots

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

TCTMD’s Top 10 Most Popular Stories for October 2023

VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli

TCT 444: Mid to Long-Term Outcomes of Transcatheter vs. Surgical Aortic Valve Replacement in Low-Risk Patients with Severe Aortic Stenosis: A Systematic Review and Meta-Analysis

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content